Amber (@amber_2926) • Threads, Say more

Brtney Amber @ 2926 Threads Say More

As part of who’s response to the outbreak, the r&d blueprint has been activated to accelerate diagnostics, vaccines and therapeutics for this novel coronavirus. In 2015, the world health organization (who), at the request of almost 200 member states, developed its first research & development (r&d) blueprint for action to prevent epidemics focusing on a number of specific severe infectious diseases for which no medical countermeasures (mcms) were available.

This report summarizes the discussions and outcomes of the meeting. The vaccines r&d 2025 conference is set to serve as a dynamic platform, fostering interdisciplinary collaboration at the cutting edge of accelerated and essential vaccine research. The r&d blueprint is a global strategy and preparedness plan that allows the rapid activation of r&d activities during epidemics

Amber (@amber_2926) • Threads, Say more

With who leadership and coordination, and using the present methodology as their basis, a series of partners will be identified to develop r&d roadmaps for each of the who priority diseases.
Amber (@amber_2926) • Threads, Say more
Amber (@amber_2926) • Threads, Say more

Details

Amber (@amber.alerrrrt) • Threads, Say more
Amber (@amber.alerrrrt) • Threads, Say more

Details

@amber_424818 • Threads, Say more
@amber_424818 • Threads, Say more

Details